argenx to Present at BofA Securities 2026 Health Care Conference
argenx (Euronext & Nasdaq: ARGX) announced that CEO Karen Massey will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
argenx (Euronext & Nasdaq: ARGX) announced that CEO Karen Massey will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT.
A live webcast will be available at argenx.com/investors, with a replay accessible on the company website for approximately 30 days after the presentation.
Details
News Market Reaction – ARGX
On May 7, the first trading day after this news, ARGX closed 2.51% below the previous close.
Data tracked by StockTitan Argus for the May 7 session.
Key Figures
- Conference date
- May 12, 2026
- Date of BofA Securities 2026 Health Care Conference presentation
- Presentation time
- 10:40 a.m. PT
- Scheduled time of argenx CEO presentation
- Webcast replay window
- 30 days
- Approximate period replay will be available on argenx website
Historical Context
-
Announced date and time for Q1 2026 financial results and business update.
-
Set Annual General Meeting date and agenda, including accounts and board items.
-
Flagged new VYVGART and pipeline neuromuscular data for the 2026 AAN meeting.
-
Reported strong 2025 results with first operating profitability and pipeline progress.
-
Announced positive Phase 3 ADAPT OCULUS results in ocular myasthenia gravis.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
May 6, 2026
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, Chief Executive Officer, will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT.
A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Instagram, Facebook, and YouTube.
Contacts
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy
aroy@argenx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.